Social network you want to login/join with:
Associate Director Parenteral Product Development, Mayo
Location: Mayo, Ireland
Job Category:
Science
EU work permit required:
Yes
Job Reference:
JN -122024-1973755_1741880929
Job Views:
4
Posted:
13.03.2025
Expiry Date:
27.04.2025
Job Description:
Associate Director, Parenteral Product Development, PDS&T
About the Opportunity:
We’re looking for a dynamic, forward-thinking leader to join a Parenteral Product Development Science & Technology (PDS&T) team. In this role, you’ll be at the forefront of transforming innovative biologic medicines, advancing from concept through commercialization. The team manages all aspects of Chemistry, Manufacturing, and Controls (CMC) related to the development and commercialization of parenteral products, including cutting-edge monoclonal antibodies, antibody-drug conjugates (ADCs), and other groundbreaking therapeutic modalities.
As part of this global team, you’ll oversee projects that span from clinical proof of concept through to market launch, contributing to our rapidly growing pipeline. We are currently seeking an individual to lead the transition of these promising pipeline products to the site, ensuring technical transfer and accelerating the path to commercialization.
Key Responsibilities:
1. Lead the transition of pipeline products, overseeing technical transfer and ensuring smooth integration into commercial readiness.
2. Collaborate closely with cross-functional teams, guiding the strategic direction for product development.
3. Leverage expertise in process development and commercial strategies to drive successful project outcomes.
4. Influence the future of biologic therapies by shaping the development of groundbreaking products.
5. Manage and contribute to projects across all stages of development, from early-phase clinical trials to full market introduction.
This role offers a unique chance to make a lasting impact on the future of biologics, working in a high-energy, collaborative environment with one of the world’s leading biopharmaceutical companies.
#J-18808-Ljbffr